Röhlig’s GDP WeCare Programme has been developed in alignment with international Good Distribution Practice (GDP) guidelines, including WHO and EU regulations. Going beyond standard GDP requirements, the programme sets a new benchmark in healthcare logistics and enables Röhlig to proactively manage quality and compliance in an increasingly complex regulatory environment.
The programme provides a tailored, controlled, and scalable framework for healthcare logistics, integrating market-specific compliance measures, enhanced training protocols, and proactive quality management across Röhlig’s global network. The certification focuses on key pillars of pharmaceutical logistics compliance, including temperature-controlled transport, deviation management, supplier qualification, risk assessment, and robust documentation standards. Through comprehensive trainings and regular internal audits, Röhlig ensures that teams worldwide are fully equipped to manage sensitive healthcare shipments in line with the highest industry expectations.
‘Building on the programme’s launch in 2025, this expansion reflects Röhlig’s ongoing commitment to ensuring the safe, compliant and reliable handling of healthcare shipments worldwide,’ says Juancarlos Cruz, Global Head of Healthcare & Life Sciences at Röhlig Logistics. ‘By implementing our own policy and programme, we ensure consistency across our global network while proactively managing risks and strengthening reliability for our healthcare customers.’
Looking ahead, the company plans to certify additional branches worldwide in 2026, further strengthening its global healthcare logistics network and reinforcing its position as a trusted partner for life science companies.
